NEW YORK — Eagle Genomics said on Monday that it has raised $9 million in funding from a group of investors led by Environmental Technologies Fund (ETF).
The investor group also included Granpool Innovated Investments, Bpd Partners, Anatom Holding, and Northeastern University researcher Albert-László Barabási.
Cambridge, UK-based Eagle said it will use the money to further develop its e[datascientist] platform, which uses artificial intelligence to analyze genomic and microbiomic data at scale for assessing the viability, efficacy, and safety of products. The company will also use the funds to continue its commercial expansion in Europe and the US.
In early 2019, Eagle closed a $3.5 million financing round, which was also led by ETF It said at the time that it would use those funds to work on e[datascientist] — formerly known as e[automateddatascientist] — and to open offices in Paris and New York.